SCHEMBL20550338

SCHEMBL20550338

O=C(Nc1cccc(OCC(O)CO)n1)N1c2nc(-c3cccc(C(F)(F)F)c3)ncc2N2CC[C@H]1C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF18A Q8NI77 6/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RAF1 P04049 5/20 0.34
▸ KCNJ6 P48051 1/20 0.33
▸ KCNJ5 P48544 1/20 0.33
▸ KCNJ3 P48549 1/20 0.33
▸ PAK1 Q13153 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ CPT2 P23786 2/20 0.33
▸ CPT1A P50416 2/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ CPT1B Q92523 1/20 0.33
▸ RPS6KA5 O75582 1/20 0.33
▸ RPS6KA4 O75676 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20550336 1.00 KIF18A (0.35) KIF18AALDH1A1KDM4ECYP2C9HPGD
SCHEMBL20550591 1.00 KIF18A (0.35) KIF18AALDH1A1KDM4ECYP2C9HPGD
SCHEMBL17769731 0.96 KIF11 (0.36) KIF18AALDH1A1KDM4ERAF1KCNJ6
SCHEMBL17769566 0.96 KIF11 (0.36) KIF18AALDH1A1KDM4ERAF1KCNJ6
SCHEMBL17769729 0.96 KIF11 (0.36) KIF18AALDH1A1KDM4ERAF1KCNJ6
SCHEMBL20550593 0.93 RAF1 (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL20550485 0.93 KDR (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17778497 0.93 RAF1 (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL20550484 0.93 KDR (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL20550380 0.93 RAF1 (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2018-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180319810-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 KIF18A 3189/4885ALDH1A1 1067/4885KDM4E 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback